Abstract:Background ATP1A3 is a gene that encodes the ATPase Na + /K + transporting subunit alpha-3 isoenzyme that is widely expressed in GABAergic neurons. It maintains metabolic balance and neurotransmitter movement. These pathways are essential for the proper functioning of the nervous system. A mutation in the ATP1A3 gene demonstrates remarkable genotype–phenotype heterogeneity. Objectives To provide insight into patients with ATP1A3 mutation. Material and methods These cases were identified using next generation sequencing. The patients' clinical and genetic data were retrieved. Detailed revision of the literature was conducted to illustrate and compare findings. The clinical, genetical, neuroimaging, and electrophysiological data of all pediatric patients were extracted. Results The study included 14 females and 12 males in addition to two novel females cases. Their mean current age is 6.3 ± 4.24 years. There were 11.54% preterm pregnancies with 5 cases reporting pregnancy complications. Mean age of seizure onset was 1.07 ± 1.06 years. Seizure semiology included generalized tonic–clonic, staring spells, tonic–clonic, and others. Levetiracetam was the most frequently used Anti-seizure medication. The three most frequently reported classical symptoms included alternating hemiplegia of childhood (50%), cerebellar ataxia (50%), and optic atrophy (23.08%). Non-classical symptoms included dystonia (73.08%), paroxysmal dyskinesias (34.62%), and encephalopathy (26.92%). Developmental delay was reported among 84.62% in cognitive, 92.31% in sensorimotor, 80.77% in speech, and 76.92% in socioemotional. EEG and MRI were non-specific. Conclusion Our study demonstrated high heterogeneity among patients with pathogenic variants in the ATP1A3 gene. Such variation is multifactorial and can be a predisposition of wide genetic and clinical variables. Many patients shared few similarities in their genetic map including repeatedly reported de novo, heterozygous, mutations in the gene. Clinically, higher females prevalence of atypical presentation was noted. These findings are validated with prior evidence and the comprehensive analysis in this study.

Functional and In-silico analysis of ATP8A2 and other P4-ATPase variants associated with human genetic diseases

Proteomic Analysis and Functional Characterization of P4-ATPase Phospholipid Flippases from Murine Tissues

A novel missense variant in the ATPase domain of ATP8A2 and review of phenotypic variability of ATP8A2-related disorders caused by missense changes

Consolidating the Role of Mutated ATP2B2 in Neurodevelopmental and Cerebellar Pathologies

Identification and functional analyses of disease-associated P4-ATPase phospholipid flippase variants in red blood cells

Substrate specificity controlled by the exit site of human P4-ATPases, revealed by de novo point mutations in neurological disorders

De Novo Missense Variations of ATP8B2 Impair Its Phosphatidylcholine Flippase Activity

ATP6V0C variants impair V-ATPase function causing a neurodevelopmental disorder often associated with epilepsy

Alternating hemiplegia of childhood associated mutations in Atp1a3 reveal diverse neurological alterations in mice.

ATP1A1-linked diseases require a malfunctioning protein product from one allele

Structural and Functional Analysis of Disease-Linked p97 ATPase Mutant Complexes

Cation leak through the ATP1A3 pump causes spasticity and intellectual disability

Childhood-related neural genotype–phenotype in ATP1A3 mutations: comprehensive analysis

Identification of a pathogenic mutation in ATP2A1 via in silico analysis of exome data for cryptic aberrant splice sites

Drosophila models used to simulate human ATP1A1 gene mutations that cause Charcot-Marie-Tooth type 2 disease and refractory seizures

ATP1A1 De Novo Mutation-Related Disorders: Clinical and Genetic Features

Phenotype Distinctions in Mice Deficient in the Neuron-Specific {alpha}3 Subunit of Na,K-ATPase: Atp1a3tm1Ling/+ and Atp1a3+/D801Y

Human H+ Atpase A4 Subunit Mutations Causing Renal Tubular Acidosis Reveal A Role for Interaction with Phosphofructokinase-1

Phenotype Distinctions in Mice Deficient in the Neuron-Specific α3 Subunit of Na,K-ATPase: Atp1a 3tm1Ling/+ and Atp1a3 +/D801Y

Disease Mutation Study Identifies Critical Residues for Phosphatidylserine Flippase ATP11A

ATP9A deficiency causes ADHD and aberrant endosomal recycling via modulating RAB5 and RAB11 activity